Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 119
Selected: 0
NCT IDTitle
NCT06218511A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
NCT01898104Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
NCT00326456MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
NCT04129281Active Surveillance Versus Surgery in Thyroid Papillary Microcarcinoma
NCT04397601Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer
NCT01074684Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT04854213PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)
NCT00657878Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT02624128Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
NCT01481545Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
NCT00431704VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast Cancer
NCT06880523STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
NCT01656551MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
NCT07290894Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
NCT01005641ELBA: Exemestane and Lapatinib in Advanced Breast Cancer
NCT06509126Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer
NCT06884878Multi-omic Approach to Cancer Diagnosis: the Italian Network of Excellence for Advanced Diagnosis (INNOVA)
NCT07577206Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.
NCT04595032MAnagement of METastatic Disease in Campania (MAMETIC)
NCT00526396STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
NCT01593488Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
NCT07459920Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden
NCT07522697Inavolisib for PIK3CA Mutated Advanced Endometrial Cancer: MITO END-4
NCT05821556Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
NCT01802749Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
NCT07302451REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
NCT01649674Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT00330746CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer
NCT00345059The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer
NCT01801904A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer
NCT02069067Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated
NCT04290299Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive
NCT06714357ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer
NCT04425239Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer
NCT01061619Pathway to Diagnosis of Ovarian Cancer
NCT04317092Tocilizumab in COVID-19 Pneumonia (TOCIVID-19)
NCT01405573Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
NCT02618850PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment
NCT07269249Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer
NCT05817227Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer.
NCT04893356Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
NCT04139772Docetaxel or Hormone Therapy as Second Line Treatment in Patients With Asymptomatic or Oligosymptomatic Metastatic Castration-resistent Prostate Cancer (mCRPC) Progressing After Abiraterone or Enzalutamide.
NCT06270602The ONCOCAMP Study
NCT00401492MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer
NCT03410784Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer
NCT01644825Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer
NCT02619435Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer
NCT00401609G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients
NCT05255471MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
NCT00660842Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer